Paul Roossin, Science Director, Nanotronics Imaging
, discusses the goals of the company to use and develop high-tech, cutting-edge microscopes and software to deliver rapid testing and analysis solutions to sectors ranging from materials science and semiconductors to life science and medicine. Recently Nanotronics received a $1 million grant to improve diagnostic testing for cervical cancer
in rural women in impoverished countries. Using imaging technology and imaging processing programs, Nanotronics is developing an automated device that can scan simple stains for atypical squamous cells
of mid grade or high grade lesions or frank carcinoma. The procedure should allow doctors to diagnose and recommend treatment within 30 minutes of a patient walking into the clinic.